Octapharma: Octapharma intros Balfaxar
Balfaxar is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients.
Read full article »
Chairman & CEO
Wolfgang Marguerre
Octapharma is a Switzerland-based pharmaceutical company that develops, produces, and sells human proteins for immunotherapy and critical care patients
Read more